Table 1.
Inclusion and exclusion criteria.
Fig 1.
The overview of the schedule for the LINQ2-HF trial.
Additional Notes: ※1: All investigations and observations related to this clinical study will be conducted after obtaining written informed consent and case registration from the study participants. Results from investigations, observations, and tests performed as part of routine clinical care prior to obtaining consent may be used as research data if conducted within 30 days prior to registration. ※2: As the baseline ECG, the rhythm will be confirmed using a monitoring ECG at the time of ILR implantation. BNP, brain natriuretic peptide; ECG, electrocardiogram; ILR, implantable loop recorder.
Fig 2.
Study flowchart of the LINQ2-HF trial.
AF, atrial fibrillation; HFrEF, heart failure with reduced ejection fraction; ILR, implantable loop recorder.